170 related articles for article (PubMed ID: 24312130)
1. Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection.
Pan N; Qiu J; Sun H; Miao F; Shi Q; Xu J; Jiang W; Jin H; Xie W; He Y; Zhang J
Clin Dev Immunol; 2013; 2013():874514. PubMed ID: 24312130
[TBL] [Abstract][Full Text] [Related]
2. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study.
Pan N; Jiang W; Sun H; Miao F; Qiu J; Jin H; Xu J; Shi Q; Xie W; Zhang J
PLoS One; 2011; 6(10):e25682. PubMed ID: 21998681
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.
Joshita S; Ota M; Kobayashi H; Wakabayashi SI; Yamashita Y; Sugiura A; Yamazaki T; Tanaka E; Umemura T
Sci Rep; 2021 Nov; 11(1):21424. PubMed ID: 34728722
[TBL] [Abstract][Full Text] [Related]
5. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
6. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.
Cariani E; Pilli M; Zerbini A; Rota C; Olivani A; Zanelli P; Zanetti A; Trenti T; Ferrari C; Missale G
Clin Cancer Res; 2013 Oct; 19(19):5465-73. PubMed ID: 23938290
[TBL] [Abstract][Full Text] [Related]
7. KIR/HLA ligands immunogenetics markers associated with outcome of hepatitis B virus infection in the Bulgarian population.
Varbanova V; Popov G; Grigorova V; Petrova D; Naumova E; Mihaylova A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Sep; 165(3):270-276. PubMed ID: 32975242
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.
Ursu LD; Calenic B; Diculescu M; Dima A; Stoian IT; Constantinescu I
Int J Immunogenet; 2021 Feb; 48(1):16-24. PubMed ID: 32961633
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
10. Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.
Hollenbach JA; Meenagh A; Sleator C; Alaez C; Bengoche M; Canossi A; Contreras G; Creary L; Evseeva I; Gorodezky C; Hardie RA; Karlsen TH; Lie B; Luo M; Martinetti M; Navarette C; de Oliveira DC; Ozzella G; Pasi A; Pavlova E; Pinto S; Porto LC; Santos P; Slavcev A; Srinak D; Tavoularis S; Tonks S; Trachtenberg E; Vejbaesya S; Middleton D
Tissue Antigens; 2010 Jul; 76(1):9-17. PubMed ID: 20331834
[TBL] [Abstract][Full Text] [Related]
11. KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.
Nozawa Y; Umemura T; Joshita S; Katsuyama Y; Shibata S; Kimura T; Morita S; Komatsu M; Matsumoto A; Tanaka E; Ota M
PLoS One; 2013; 8(12):e83381. PubMed ID: 24349500
[TBL] [Abstract][Full Text] [Related]
12. Killer Cell Immunoglobulin-Like Receptor Genotypes and Haplotypes Contribute to Susceptibility to Hepatitis B Virus and Hepatitis C Virus Infection in Cameroon.
Torimiro J; Yengo CK; Bimela JS; Tiedeu AB; Lebon PA; Sake CS; Kouanfack C; Nchinda G; Rowland-Jones S; Yindom LM
OMICS; 2020 Feb; 24(2):110-115. PubMed ID: 31977279
[TBL] [Abstract][Full Text] [Related]
13. Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.
De Re V; Caggiari L; De Zorzi M; Repetto O; Zignego AL; Izzo F; Tornesello ML; Buonaguro FM; Mangia A; Sansonno D; Racanelli V; De Vita S; Pioltelli P; Vaccher E; Berretta M; Mazzaro C; Libra M; Gini A; Zucchetto A; Cannizzaro R; De Paoli P
PLoS One; 2015; 10(2):e0117420. PubMed ID: 25700262
[TBL] [Abstract][Full Text] [Related]
14. KIR : HLA association with clinical manifestations of HBV infection in Madurai, south India.
Kalyanaraman N; Thayumanavan L; Jayalakshmi M
J Genet; 2016 Mar; 95(1):13-9. PubMed ID: 27019428
[TBL] [Abstract][Full Text] [Related]
15. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients.
Umemura T; Joshita S; Saito H; Wakabayashi SI; Kobayashi H; Yamashita Y; Sugiura A; Yamazaki T; Ota M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209910
[TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of HLA Gene Variants in HBV Infection.
Wang L; Zou ZQ; Wang K
J Immunol Res; 2016; 2016():9069375. PubMed ID: 27243039
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma.
Song C; Liu Y; Xu L; Wen J; Jiang D; Chen J; Zhai X; Hu Z; Liu L; Liu J
Cancer Med; 2016 Jul; 5(7):1687-93. PubMed ID: 27075395
[TBL] [Abstract][Full Text] [Related]
19. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
20. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
